Bromperidol maintenance in schizophrenia.
Publication
, Journal Article
McEvoy, JP; Wilson, WH; Ban, TA; Brannen, JO; Berney, S
Published in: Pharmacopsychiatria
1982
Twenty-three patients who completed a four-week, double-blind, clinical trial of bromperidol versus haloperidol were treated with bromperidol for eight additional weeks in a continuation study. Over 87 percent of patients maintained their improved status or showed further improvement. Extrapyramidal signs were frequent, but required discontinuation of treatment in only two patients.
Duke Scholars
Published In
Pharmacopsychiatria
Publication Date
1982
Volume
15
Issue
3
Start / End Page
95 / 96
Citation
APA
Chicago
ICMJE
MLA
NLM
McEvoy, J. P., Wilson, W. H., Ban, T. A., Brannen, J. O., & Berney, S. (1982). Bromperidol maintenance in schizophrenia. Pharmacopsychiatria, 15(3), 95–96.
McEvoy, J. P., W. H. Wilson, T. A. Ban, J. O. Brannen, and S. Berney. “Bromperidol maintenance in schizophrenia.” Pharmacopsychiatria 15, no. 3 (1982): 95–96.
McEvoy JP, Wilson WH, Ban TA, Brannen JO, Berney S. Bromperidol maintenance in schizophrenia. Pharmacopsychiatria. 1982;15(3):95–6.
McEvoy, J. P., et al. “Bromperidol maintenance in schizophrenia.” Pharmacopsychiatria, vol. 15, no. 3, 1982, pp. 95–96.
McEvoy JP, Wilson WH, Ban TA, Brannen JO, Berney S. Bromperidol maintenance in schizophrenia. Pharmacopsychiatria. 1982;15(3):95–96.
Published In
Pharmacopsychiatria
Publication Date
1982
Volume
15
Issue
3
Start / End Page
95 / 96